Tom Nolan’s research reviews—7 April 2022
Biliary no matesSodium-glucose co-transporter-2 (SGLT2) inhibitors seem to be the talk of the town for type 2 diabetes at the moment, as they may help with weight loss and reduction in cardiovascular…
Read Original Article: Tom Nolan’s research reviews—7 April 2022 »
